virus
possess
abil
chang
machineri
live
host
bodi
benefit
continu
surviv
thu
categor
live
organ
parasit
viru
categor
invas
capabl
infect
show
pathogen
mcfadden
host
cell
possess
abil
evolv
carri
variou
network
defens
measur
pathogen
microbi
pathogen
abil
neutral
defens
measur
host
cell
render
useless
mcfadden
challeng
puzzl
job
identifi
complex
host
respons
occur
viral
infect
encount
live
host
requir
find
categor
variou
host
factor
could
involv
activ
cycl
viru
infect
moreov
also
need
categor
identifi
host
respons
qualit
quantit
categori
viral
pathogenesi
zheng
et
al
multipl
exist
techniqu
identifi
virus
tradit
techniqu
use
discov
mani
wellknown
virus
consist
electron
microscopi
inocul
studi
cell
cultur
serolog
storch
techniqu
lot
limit
fact
virus
small
size
cultur
laboratori
rather
character
util
molecular
method
howev
numer
technolog
advanc
field
virolog
advanc
technolog
set
preced
metagenom
studi
collect
microbi
popul
call
microbiom
cultureindepend
studi
analyz
content
nucleotid
sequenc
sampl
petrosino
et
al
studi
viral
microbiom
also
known
virom
conduct
differ
sampl
biolog
environment
applic
human
anim
water
soil
plant
breitbart
et
al
zhang
et
al
finkbein
et
al
schoenfeld
et
al
fierer
et
al
metagenom
sequenc
make
possibl
find
function
potenti
hidden
microbiom
code
moreov
metagenom
analys
util
discov
novel
enzymat
function
well
microorgan
gene
could
possibl
util
bioremedi
russel
et
al
lovley
better
knowhow
interact
also
creat
novel
therapeut
strategi
could
use
human
diseas
howev
metagenom
limit
variat
dna
accord
site
bodi
type
sampl
exampl
sputum
sampl
sampl
lung
tissu
cystic
fibrosi
contain
larg
quantiti
human
dna
releas
neutrophil
bodi
show
immun
respons
even
amount
total
dna
breitenstein
et
al
present
year
virolog
undergo
rapid
advanc
result
highthroughput
genom
sequenc
proteom
screen
technolog
progress
proteom
screen
technolog
proteom
base
mass
spectrometri
larg
encourag
research
inquiri
viral
proteom
also
respons
host
relat
viral
infect
zheng
et
al
mass
spectrometri
one
core
emerg
part
import
discoveri
made
field
virolog
cell
form
complex
evolutionari
relat
dynam
interact
work
either
sponsor
viru
replic
help
host
carri
defens
pathogen
invad
host
cell
bodi
viral
cell
promot
multipl
proteom
chang
make
understand
viru
molecular
level
difficult
task
requir
breadth
indepth
analysi
infect
mass
spectrometri
solut
bridg
gap
experiment
dichotomi
use
unbias
system
analysi
hypothesisrun
studi
fasten
pace
discoveri
area
viru
pathogen
defens
host
greco
et
al
mass
techniqu
use
investig
host
virus
virus
follow
mass
techniqu
applic
virolog
tandem
affin
purif
tap
mass
spectrometri
techniqu
take
role
explain
interact
use
studi
protein
proteom
structur
import
studi
evolut
viral
protein
virus
replic
within
host
cell
jorba
et
al
use
dual
epitop
tag
continu
immunoaffin
isol
use
cell
infect
virus
techniqu
use
isol
vaccinia
viru
call
well
protein
done
use
streptavidin
calmodulinattach
tap
system
viru
protein
separ
local
surfac
cell
need
interact
entri
fuse
complex
moss
mass
spectrometri
techniqu
use
identifi
compon
bind
target
protein
coimmunoprecipit
perform
either
singlestep
process
compon
tandem
purif
obtain
target
solut
antibodi
target
known
member
complex
attach
bead
incub
lysat
antibodi
use
coimmunoprecipit
recogn
protein
interest
tag
protein
made
genet
fuse
tag
protein
concern
altern
way
perform
coimmunoprecipit
use
molecular
tag
bind
protein
interest
express
transgen
purifi
use
antibodi
ad
tag
tag
use
tandem
purif
multior
singlestep
purif
schaffer
et
al
techniqu
use
defin
protein
local
caenorhabd
elegan
experiment
design
sever
tag
construct
use
c
elegan
reason
behind
function
effect
ad
singl
tag
usual
known
therefor
differ
tag
attach
c
n
terminu
function
tag
protein
determin
abl
extract
phenotyp
null
mutant
moreov
common
use
green
fluoresc
protein
govern
protein
local
c
elegan
also
conduct
singlestep
process
purif
zhang
et
al
hla
peptidom
scan
mass
spectrometri
approach
techniqu
use
look
peptid
associ
diseas
well
mutant
differ
express
protein
host
cell
viral
infect
exampl
use
techniqu
defens
mechan
employ
cytotox
lymphocyt
within
human
bodi
intracellular
pathogen
attack
bodi
hla
class
associ
immunopeptid
mass
spectrometri
becom
import
tool
increas
understand
tcell
respons
pathogen
exampl
ternett
et
al
sever
approach
use
discov
pathogen
includ
hybrid
pcrbase
method
effect
method
mention
earlier
base
pcr
hybrid
establish
viru
interest
us
first
purifi
host
cell
nucleic
acid
contamin
amplifi
product
identifi
sequenc
present
day
advanc
sequenc
led
us
era
secondgener
sequenc
huge
chunk
data
sequenc
one
go
petrosino
et
al
section
provid
descript
current
hybrid
pcr
techniqu
detect
virus
affect
anim
microarray
made
probe
oligonucleotid
high
densiti
word
portion
dna
immobil
solid
surfac
sequenc
made
complementari
strand
present
test
sampl
tag
fluoresc
nucleotid
hybrid
probe
present
microarray
hybrid
observ
follow
quantif
use
observ
method
base
fluoresc
establish
result
way
rel
abund
profus
sequenc
nucleic
acid
sampl
found
clewley
two
type
techniqu
microarray
util
identif
viru
first
util
short
oligonucleotid
probe
util
long
oligonucleotid
probe
techniqu
util
short
oligonucleotid
probe
use
detect
human
herp
viru
foldespapp
et
al
applic
microarray
util
discov
virus
anim
exampl
beluga
whale
found
coronaviru
mihindukulasuriya
et
al
technolog
use
microarray
consid
import
tool
viral
screen
use
screen
huge
amount
pathogen
concurr
principl
subtract
hybrid
remov
sequenc
nucleic
acid
common
two
relat
sampl
leav
behind
differ
sequenc
differenti
sequenc
two
relat
sampl
two
sourc
nucleic
acid
call
tester
driver
tester
consist
pathogen
sequenc
ambros
clewley
restrict
enzym
use
digest
dna
present
tester
driver
note
dna
fragment
tester
sampl
ligat
adapt
next
two
popul
dna
first
mix
denatur
segment
end
anneal
form
four
molecul
tester
tester
hybrid
tester
driver
driverdriv
method
viru
suffici
enrich
sampl
tester
sequenc
identifi
pathogen
util
primer
specif
design
manufactur
anneal
highli
conserv
sequenc
region
mutual
relat
virus
primer
design
includ
degeneraci
allow
attach
commonli
recogn
variant
conserv
sequenc
region
usual
entir
conserv
degener
primer
util
detect
virus
includ
novel
virus
exist
viral
homolog
famili
exampl
use
primer
rabbit
use
detect
alphaherpesviru
link
death
jin
et
al
random
pcr
use
conduct
microarray
analysi
amplif
label
probe
use
fluoresc
dye
also
associ
identifi
novel
virus
random
pcr
util
two
differ
pcr
reaction
two
differ
primer
singular
primer
util
initi
pcr
distinct
sequenc
degener
hexam
end
next
pcr
reaction
done
anoth
differ
specif
primer
complementari
region
initi
primer
allow
amplif
first
product
creat
initi
reaction
random
pcr
use
find
rna
dna
virus
use
identif
unknown
virus
exampl
viru
found
random
pcr
includ
circular
dna
viru
found
fece
wild
chimpanze
blinkova
et
al
seal
picornaviru
kapoor
et
al
gener
metatranscriptom
experi
includ
seclus
complet
rna
microbiom
follow
enrich
rna
depend
type
rna
sequenc
exampl
mrna
lincrna
microrna
rna
fragment
small
piec
cdna
synthes
use
revers
transcriptas
random
oligo
dt
primer
next
step
includ
repair
end
end
cdna
follow
ligat
adapt
librari
clean
amplif
quantif
carri
lastli
librari
sequenc
liu
graber
ozsolak
milo
ozsolak
et
al
hickman
et
al
howev
largescal
use
metatranscriptom
limit
follow
storag
collect
rna
sampl
problem
obtain
suffici
amount
highqual
rna
human
microbiom
sampl
enrich
mrna
remov
rrna
short
life
mrna
limit
transcriptom
databas
contamin
host
rna
lastli
polya
rna
collect
kit
requir
store
mrna
popul
usabl
prokaryot
bikel
et
al
metatranscriptom
becom
practic
tool
analyz
regul
dynam
transcript
activ
microb
use
metagenom
combin
metatranscriptom
enabl
us
observ
gut
microbiom
result
show
uniqu
group
activ
microorgan
differ
individu
benitezpaez
et
al
franzosa
et
al
potenti
combin
metagenom
metatranscriptom
observ
look
franzosa
studi
franzosa
et
al
state
fraction
almost
microbi
transcript
differenti
regul
rel
genom
abund
furthermor
depict
quantiti
gene
famili
mani
less
abund
metagenom
level
turn
quit
activ
level
metatranscriptom
vice
versa
franzosa
et
al
conclud
perform
one
two
techniqu
alon
could
lead
underestim
overestim
function
relev
gene
encod
metagenom
author
also
add
function
divers
level
transcript
display
subjectspecif
metagenom
regul
pattern
measur
function
top
gene
famili
specif
analyz
individu
franzosa
et
al
larg
portion
antivir
therapeut
avail
market
involv
inhabit
viral
protein
show
catalyt
abil
virus
encod
necessari
enzym
uniqu
cellular
gene
may
make
easier
target
specif
therapeut
scientist
util
properti
appli
highthroughput
small
molecular
screen
technolog
enzym
assay
target
base
determin
specif
drug
could
inhibit
viral
protein
easier
appli
techniqu
virus
limit
code
abil
easier
identifi
specif
compound
target
viral
protein
techniqu
still
research
recent
employ
util
small
molecul
librari
call
test
influenza
viru
vesicular
stomat
viru
vsv
infect
use
niemannpick
cellular
receptor
ebola
viru
chen
et
al
virus
virtu
structur
depend
host
cellular
process
dna
replic
rna
cap
splice
translat
transport
messeng
rna
accomplish
replic
genom
invad
host
machineri
surviv
cherri
process
viral
protein
interact
host
cell
protein
assist
process
multipl
sophist
technolog
use
understand
complet
process
viral
genom
interact
host
cell
genom
use
host
cell
factor
complet
identif
possibl
due
absenc
systemat
methodolog
recent
progress
develop
novel
techniqu
studi
cellular
factor
involv
interact
made
possibl
develop
detail
underst
watanab
et
al
develop
rna
interfer
rnai
method
brought
possibl
studi
lossoffunct
screen
meliopoulo
et
al
recent
advanc
highthroughput
screen
use
viru
exampl
list
section
antivir
drug
work
inhibit
viral
protein
therefor
hamper
complet
molecular
mechan
need
complet
viral
genom
replic
virus
encod
special
enzym
distinct
host
cell
enzym
screen
enzym
help
develop
drug
inhibit
viral
replic
cycl
previous
screen
target
protein
led
develop
librari
use
pharmaceut
industri
develop
antivir
drug
interest
exact
target
protein
interest
still
mark
unknown
diseas
therefor
room
improv
explor
develop
targetbas
biochem
assay
cellbas
assay
use
pinpoint
target
compound
use
viral
protein
sinc
virus
limit
code
capac
screen
provid
straightforward
evid
whether
specif
compound
hamper
viral
replic
process
target
viral
protein
compound
target
way
identif
cellular
pathway
possibl
compound
screen
techniqu
new
target
virus
discov
use
techniqu
exampl
share
tabl
method
develop
therapeut
molecul
use
small
molecul
target
moleculecompound
screen
work
success
variou
diseas
limit
method
overcom
use
revers
genet
screen
method
directli
reveal
sequenc
target
molecul
mata
et
al
et
al
filon
et
al
one
basic
techniqu
use
genet
screen
gainoffunct
method
lossoffunct
approach
gainoffunct
approach
function
specif
gene
probe
help
ectop
cdna
rnai
methodolog
use
develop
lossoffunct
screen
differ
rnai
tool
short
hairpin
rna
small
interf
rna
long
doublestrand
rna
commerci
avail
tool
use
purpos
compar
genom
profil
help
find
potenti
virus
famili
differ
famili
target
enzym
protein
cellular
factor
screen
protein
give
modest
target
protein
rnai
screen
minim
overlap
viru
stertz
shaw
comparison
virus
group
made
exampl
compar
screen
coxsackieviru
b
polio
viru
infect
polar
endotheli
cell
perform
host
factor
depend
overlap
observ
coyn
et
al
genom
profil
studi
reveal
high
level
depend
flavivirus
krishnan
et
al
compar
genom
profil
perform
gene
set
lymphocyt
choriomening
viru
varicella
zoster
viru
human
parainfluenza
viru
type
reveal
three
virus
similar
valid
gene
panda
et
al
